VTP50469 is a novel, orally available menin-MLL1 inhibitor effective against MLL-rearranged and NPM1-mutant leukemiaAndrei V. Krivtsov,Benjamin K. Eschle,Matthew Witkin,Jayant Y. Gadrey,Hannah J. Uckelmann,Sayuri Kitajima,Gerard M. McGeehan,Scott A. ArmstrongCANCER RESEARCH(2018)引用 1|浏览28暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要